Researchers have
indicated that they want access to novel target antibodies
quickly to aid in their research. IMGENEX is therefore pleased to be
able to offer researchers access to products that are not fully
characterized or validated. IMGENEX IMX antibodies are shown by
Peptide ELISA to bind to the peptide used as immunogen. Investigators
should empirically determine the suitability of the antibody,
including optimal dilutions, for other applications of interest.
We cannot guarantee that the IMX antibody will work in any
application other than in a Peptide ELISA against the peptide used
as immunogen and therefore can not offer a refund if the antibody
does not work in your application.
IMX antibodies are offered at a lower price compared to more
highly validated antibodies.
We are not able to provide the peptide used as immunogen for
IMX antibodies.
As IMX antibodies are not fully validated we appreciate your
feedback. Customer feedback is used to help generate testing
methodologies which can lead to further product validation or
withdrawal.
F-box only protein 9 is a Ubl conjugation pathway protein and
it contains one F-box domain and one TPR repeat. FBXO9 may act as a
potential sepsis biomarker or therapeutic target. The F-box proteins
constitute one of the four subunits of the ubiquitin protein ligase
complex called SCFs (SKP1-cullin-F-box), which functions in
phosphorylation-dependent ubiquitination.
Antigen
Amino acids 8-25 CHSDADRVGDEGNESPAE of
mouse FBXO9 protein were used as the immunogen.